BillionaireNet
Xiulian
Fan Xiulian
Rank #2173
CHINAHealthcarePharmaceuticals

Fan Xiulian

Net Worth
$1.749B
-1.55% (24h)
Fan Xiulian, a prominent figure in the Chinese pharmaceutical industry, is the CEO of Haisco Pharmaceutical Group. Her career has been marked by her entrepreneurial spirit and strategic vision. Her source of wealth comes from the pharmaceutical industry. Currently, Fan Xiulian's net worth is estimated at $2.0 billion. Her company is known for specialty pharmaceuticals, including those for anesthesia, oncology antiemetics, and cardiovascular treatments. Fan co-founded the precursor to Haisco with Wang Junmin in 2000, and she ascended to the vice chairpersonship in 2007. Haisco went public on the Shenzhen Stock Exchange in 2012, marking a significant milestone in her career. As of 2025, Fan Xiulian is ranked #2933 on Forbes' Billionaires list.

The Full Dossier

Early Life and Career Beginnings

Born in Mainland China, Fan Xiulian's early life and educational background laid the foundation for her future success. She graduated from Guangzhou's South China University of Technology. Fan's journey in the pharmaceutical industry began with a collaborative venture.

Rise to Success

Fan Xiulian, along with Wang Junmin, co-founded the precursor to Haisco in 2000. Her strategic acumen and leadership were instrumental in the company's growth. She became the vice chairperson of Haisco in 2007, a pivotal moment that solidified her role in the company's leadership. The company's IPO on the Shenzhen Stock Exchange in January 2012 marked a significant milestone, propelling her net worth.

Key Business Strategies

Fan Xiulian focused on expanding Haisco's product line and capitalizing on the burgeoning healthcare market in China. The company's focus on R&D has been a critical strategy, with an emphasis on bringing new pharmaceutical products to market. She emphasized boosting brand image and expanding the drugmaker's portfolio.

Philanthropy

While specific details about Fan Xiulian's philanthropic initiatives are not readily available, her commitment to her company's roots is evident. Haisco has contributed to the local economy and community development, showing a commitment to giving back.

Career Timeline

2012

Haisco IPO

Haisco Pharmaceutical Group went public on the Shenzhen Stock Exchange, a significant financial milestone.

2007

Became Vice Chairperson of Haisco

Assumed a key leadership role, contributing to the strategic direction and growth of the company.

2000

Co-founded the precursor to Haisco

Established a foundational company that would later evolve into Haisco Pharmaceutical Group.

Philanthropic Impact

Community DevelopmentUnknown

Community development in Tibet

Supported the local economy and community development in Tibet, reflecting a commitment to the origins of the company's success.

Wealth Trajectory